Healthcare Market Research Worldwide

Product Lifecycle

Smarter Insights. Sharper Strategy. Stronger Results.

Whether you’re evaluating an early asset, preparing for launch, or optimizing an in-market product, APLUSA delivers research solutions across the product development lifecycle that help you de-risk decisions, uncover opportunities, and drive meaningful impact for your brands.

We support pharmaceutical and biotech teams across three key phases of the product journey, each with its own challenges, and each requiring distinct strategic insights.

  • Pipeline Assets
    Identify opportunities and guide investment decisions.
    • Size Patient Populations
    • Identify Unmet Needs
    • Uncover Signals of Future Uptake
    • Guide Go/No-go Decisions
    More →
  • Pre-Launch
    Build launch strategies that will maximize adoption.
    • Demand Assessment
    • Physician & Patient Segmentation
    • Model Adoption Behavior
    • Brand Communication Optimization
    More →
  • In-line
    Track what matters. Grow where it counts.
    • Brand Performance Intelligence
    • Sales Force Effectiveness
    • Message Recall
    • Patient Profiling
    More →

Our Research Design Philosophy.

Rational Drivers
Identifying rational levers to shape behavior.
Custom, real-life quantitative methodologies to understand the functional and clinical factors influencing treatment choices.
Patient Charts
Actual prescribing behavior.
Emotional Drivers
Exploring the psyche to reveal hidden truths.
Revealing underlying beliefs, biases, and perceptions that shape HCP choices beyond the clinical rationale to bring research outcomes to life.
Hidden Drivers
Uncovering unspoken patterns & future behavior.
Identifying unarticulated drivers of current behavior and using demand-based techniques to project future behavior.

Let's Talk

Éric Yönter
Partnership Strategy Director
Paul Taylor
Partnership Strategy Director
Back

Éric Yönter

Partnership Strategy Director

Eric has joined APLUSA after over 20 years dedicated at growing exceptional relationships with clients in the pharmaceutical industry across Europe and Asia. Eric brings in a solid expertise in the sale of services (market research studies, databases, panels of physicians and pharmacies) to help implementing, together with our Business Unit Directors and experts, commercial partnerships that will match even more our clients’ expectations.

Graduate of the Ecole Supérieure de Gestion (now Paris School of Business), Eric also holds a master’s degree in economic and social administration from the University of Paris-Assas and an Executive MBA in healthcare management from the University of Paris-Dauphine.

Back

Paul Taylor

Partnership Strategy Director

Paul has been working in international healthcare market research for over 20 years, and is based in our London office. Paul is responsible for supporting global and UK-based clients with their needs across all therapy areas and methodologies. Paul enjoys studies that include patients, as well as those relating to medical devices, and spent numerous years working with longitudinal data from hospital records in Europe.

Paul has previously worked with Aequus Research, Medimix and IQVIA, successfully developing new business among pharmaceutical and Biotech clients in Europe, Japan, Latin America and the USA. Paul has a wealth of experience within various therapeutic classes, noticeably in Oncology and Multiple Sclerosis as well as Diabetes, Epilepsy, HIV, pain management and Anti-Infectives.